M L Crismon
Lynn Crismon's research and practice focus on pharmacotherapeutic interventions and methodologies to improve the clinical outcomes of individuals with severe mental illnesses and brain disorders. His current research priority is the Texas Medication Algorithm Project (TMAP), of which he is project co-director. TMAP is a multi-institutional, collaborative research effort of the Texas Department of Mental Health and Mental Retardation, UT Austin College of Pharmacy, UT Southwestern Medical Center and three other Texas medical schools. This multi-disciplinary project, designed to evaluate the clinical and economic outcomes of medication algorithm-driven treatment for the severely and persistently mentally ill, has received $6.5 million in funding, including major awards from the Robert Wood Johnson Foundation and the Meadows Foundation. Other ongoing research includes the Children?s Medication Algorithm Project for which he is the director; a consensus development project for psychotropic drug use in the mentally retarded; a prospective evaluation of the costs of Alzheimer?s disease; and evaluations of psychiatric pharmacy services. Crismon has more than 115 articles, chapters or handbooks and over 96 abstracts in print or press. He has delivered more than 245 invited lectures or presentations. He is associate editor of the American Pharmaceutical Association?s "Drug Treatment Protocols Project," a member of the editorial advisory board for "The Annals of Pharmacotherapy "and a reviewer for numerous journals.